One-year cardiovascular event rates in outpatients with atherothrombosis.
about
Antiplatelet agents for intermittent claudicationAssessing Risk in Patients with Stable Coronary Disease: When Should We Intensify Care and Follow-Up? Results from a Meta-Analysis of Observational Studies of the COURAGE and FAME EraCritical Limb Ischemia: Current Trends and Future DirectionsInternal Iliac Artery Stenosis: Diagnosis and How to Manage it in 2015Anticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decadeRole of coronary physiology in the contemporary management of coronary artery diseaseIs there a consistent association between coronary heart disease and ischemic stroke caused by intracranial atherosclerosis?Non-coronary atherosclerosisExercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefitsClinical updates on carvedilol: a first choice beta-blocker in the treatment of cardiovascular diseasesPractice-based evidence: profiling the safety of cilostazol by text-mining of clinical notesDigital ankle-brachial index technology used in primary care settings to detect flow obstruction: a population based registry studyHeart disease and stroke statistics--2011 update: a report from the American Heart AssociationPeripheral artery disease: epidemiology and global perspectives.Echocardiographic evaluation of aorto-iliac occlusive disease.Relationship between central and peripheral atherosclerosis and left ventricular dysfunction in a community population.The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-year follow-up data from the Australian REACH registry.Cross vascular risk for first and recurrent hospitalised atherothrombosis determined retrospectively from linked data.Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.One third of hospital costs for atherothrombotic disease are attributable to readmissions: a linked data analysisAssociation between polyvascular atherosclerosis and estimated glomerular filtration rate in patients with ischaemic stroke: data analysis of the patients in the Chinese National Stroke Registry.Individual assessment of arteriosclerosis by empiric clinical profilingRisk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data.Assessment of atherothrombosis and its treatment in Mexico: first-year data of the REACH Registry.Prevalence of peripheral arterial disease in patients at non-high cardiovascular risk. Rationale and design of the PANDORA studyCritical limb ischemiaIs it cost-effective to increase aspirin use in outpatient settings for primary or secondary prevention? Simulation data from the REACH Registry Australian Cohort.Inclusion of stroke as an outcome and risk equivalent in risk scores for primary and secondary prevention of vascular disease.Prevalence of asymptomatic critical carotid artery stenosis in Korean patients with chronic atherosclerotic lower extremity ischemia: is a screening carotid duplex ultrasonography worthwhile?Effect of ischemic and pharmacological preconditioning of lower limb muscle tissue on tissue oxygenation measured by near-infrared spectroscopy--a pilot studyThe combination of 9p21.3 genotype and biomarker profile improves a peripheral artery disease risk prediction model.One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry.Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease.Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort.Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men.Heart failure in acute ischemic strokeOxidative stress markers are associated to vascular recurrence in non-cardioembolic stroke patients non-treated with statins.Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy.Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registryBone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients.
P2860
Q24235178-EC0B5B54-55B1-4A61-BD85-D86A5FEA4D43Q26745091-27223B15-8A26-4BCC-98F5-CF2185EE996EQ26767021-9105E9D4-8DFF-4910-87F4-466A6461F342Q26776106-273733DA-7054-4AE9-92DF-BE5389FDAD2DQ26824864-6699EAF0-0901-490C-8FCC-6DE0BAB13517Q26827566-7F3F39B7-104F-4FA9-BE13-FC7C3CDD276BQ26851408-968654AF-52F2-4C12-BA99-BC74048582E1Q27024872-CA20A8A4-257A-4D7B-9300-EA1C53BF8D9DQ27694706-1A88E4AF-5C5A-4535-ADD5-BC8F901536DBQ28270431-C265246B-4344-4A8D-91C6-D4E98B39D21AQ28533275-8CA8367D-E780-4F81-A966-4A755B39CA08Q28660921-5D75479F-3E16-4956-8275-D9663E3C7FECQ29547236-9DA3A486-D01D-4AE4-8A74-6C603D0ED2C9Q30241154-E86A6A65-58FB-4D97-9139-B5A93DFD27B5Q30462697-866D8B5E-B1DF-4C62-ADA6-B763FC0291FFQ30471872-D8F930A5-DFC6-4DD6-B36B-1D2AF595AF02Q30615846-F44C3B0E-EA78-40BB-90BB-AC157DFD3F50Q30698636-27E188ED-509E-4EDB-9A8C-5DBA7753B864Q30821177-1975F7D5-D1A0-4958-9C50-D028739D0B75Q30841242-9A0467DE-F7AA-4354-ABC7-F8610528A108Q30937316-2CF6B225-F12E-4B7F-A246-29504AD80513Q33307524-7E612A00-D588-4788-9CC8-43715261CD94Q33396890-D30AC1D2-1C2C-446C-864B-BBAE82FB5E2AQ33635617-66F9A3AB-6B97-42D9-9395-4982C15B8649Q33650331-2C49A022-4B5D-4A21-BE93-1CEFC15781CEQ33814176-6F260520-E65D-47D7-9F8E-1F1DD66C71CBQ34007717-942F06FA-A0D1-411D-AA60-1C00C8D122BDQ34010411-344DEE53-B9EA-4DB8-A04E-0CD87E8CE130Q34014754-DBB03CDA-E8A2-48C2-927E-7B633786A2FBQ34051830-D299DBA7-E470-44CB-AE8D-5F7F78B8F742Q34140830-3543BAD4-0B7C-4870-A661-B22A9AABA444Q34196725-C3946AA9-EF50-4677-BE40-7269871A11F7Q34255442-B45E5856-3B01-44F9-8C10-9CD038878270Q34281450-865FAA73-14F6-4694-8A01-63FC193A3A8FQ34307833-EED4F961-CE3C-4746-B790-CB8606F25964Q34362887-45413718-FCEC-462C-9B70-18879D866D05Q34365602-A469929B-7C7A-41E4-A81F-351D5C98DC6CQ34396234-EBBEEBF8-F431-4090-8CE9-CED045434A60Q34436787-FAEFC4CD-497B-40D5-87A3-3C2F305ABCAEQ34576771-18F69CAF-6770-4AA0-AF53-36E8093F8C73
P2860
One-year cardiovascular event rates in outpatients with atherothrombosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
One-year cardiovascular event rates in outpatients with atherothrombosis.
@en
One-year cardiovascular event rates in outpatients with atherothrombosis.
@nl
type
label
One-year cardiovascular event rates in outpatients with atherothrombosis.
@en
One-year cardiovascular event rates in outpatients with atherothrombosis.
@nl
prefLabel
One-year cardiovascular event rates in outpatients with atherothrombosis.
@en
One-year cardiovascular event rates in outpatients with atherothrombosis.
@nl
P2093
P50
P356
P1476
One-year cardiovascular event rates in outpatients with atherothrombosis.
@en
P2093
Alan T Hirsch
Chiau-Suong Liau
Deepak L Bhatt
Jean-Louis Mas
Joachim Röther
Peter W F Wilson
REACH Registry Investigators
Ralph D'Agostino
Shinya Goto
Yasuo Ikeda
P304
P356
10.1001/JAMA.297.11.1197
P407
P577
2007-03-01T00:00:00Z